Literature DB >> 27741214

Diagnostic value of 18F-FDG-PET/CT for the evaluation of solitary pulmonary nodules: a systematic review and meta-analysis.

Zong Ruilong1, Xie Daohai, Geng Li, Wang Xiaohong, Wang Chunjie, Tian Lei.   

Abstract

OBJECTIVES: To carry out a meta-analysis on the performance of fluorine-18-fluorodeoxyglucose (F-FDG) PET/computed tomography (PET/CT) for the evaluation of solitary pulmonary nodules.
MATERIALS AND METHODS: In the meta-analysis, we performed searches of several electronic databases for relevant studies, including Google Scholar, PubMed, Cochrane Library, and several Chinese databases. The quality of all included studies was assessed by Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2). Two observers independently extracted data of eligible articles. For the meta-analysis, the total sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratios were pooled. A summary receiver operating characteristic curve was constructed. The I-test was performed to assess the impact of study heterogeneity on the results of the meta-analysis. Meta-regression and subgroup analysis were carried out to investigate the potential covariates that might have considerable impacts on heterogeneity.
RESULTS: Overall, 12 studies were included in this meta-analysis, including a total of 1297 patients and 1301 pulmonary nodules. The pooled sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio with corresponding 95% confidence intervals (CIs) were 0.82 (95% CI, 0.76-0.87), 0.81 (95% CI, 0.66-0.90), 4.3 (95% CI, 2.3-7.9), and 0.22 (95% CI, 0.16-0.30), respectively. Significant heterogeneity was observed in sensitivity (I=81.1%) and specificity (I=89.6%). Subgroup analysis showed that the best results for sensitivity (0.90; 95% CI, 0.68-0.86) and accuracy (0.93; 95% CI, 0.90-0.95) were present in a prospective study.
CONCLUSION: The results of our analysis suggest that PET/CT is a useful tool for detecting malignant pulmonary nodules qualitatively. Although current evidence showed moderate accuracy for PET/CT in differentiating malignant from benign solitary pulmonary nodules, further work needs to be carried out to improve its reliability.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27741214     DOI: 10.1097/MNM.0000000000000605

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  22 in total

1.  A comparison study of dual-energy spectral CT and 18F-FDG PET/CT in primary tumors and lymph nodes of lung cancer.

Authors:  Osman Kupik; Yavuz Metin; Gülnihan Eren; Nurgul Orhan Metin; Medeni Arpa
Journal:  Diagn Interv Radiol       Date:  2021-03       Impact factor: 2.630

2.  Use of radiomics based on 18F-FDG PET/CT and machine learning methods to aid clinical decision-making in the classification of solitary pulmonary lesions: an innovative approach.

Authors:  Yi Zhou; Xue-Lei Ma; Ting Zhang; Jian Wang; Tao Zhang; Rong Tian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-05       Impact factor: 9.236

3.  Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial.

Authors:  Laura Evangelista; Alberto Cuocolo; Leonardo Pace; Luigi Mansi; Silvana Del Vecchio; Paolo Miletto; Silvia Sanfilippo; Sara Pellegrino; Luca Guerra; Giovanna Pepe; Giuseppina Peluso; Marco Salvatore; Rosj Galicchio; Michele Zuffante; Salvatore Annunziata; Mohsen Farsad; Agostino Chiaravalloti; Marco Spadafora
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-07       Impact factor: 9.236

4.  Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions.

Authors:  Margarita Kirienko; Luca Cozzi; Alexia Rossi; Emanuele Voulaz; Lidija Antunovic; Antonella Fogliata; Arturo Chiti; Martina Sollini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-06       Impact factor: 9.236

5.  Prone position [18F]FDG PET/CT to reduce respiratory motion artefacts in the evaluation of lung nodules.

Authors:  Hyung Ju Lee; Hye Joo Son; Mijin Yun; Jung Won Moon; Yoo Na Kim; Ji Young Woo; Suk Hyun Lee
Journal:  Eur Radiol       Date:  2021-04-14       Impact factor: 5.315

Review 6.  Physician centred imaging interpretation is dying out - why should I be a nuclear medicine physician?

Authors:  Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-07       Impact factor: 9.236

7.  How to diagnose pulmonary nodules: from screening to therapy.

Authors:  Yanwen Yao; Tangfeng Lv; Yong Song
Journal:  Transl Lung Cancer Res       Date:  2017-02

8.  PET/MRI assessment of lung nodules in primary abdominal malignancies: sensitivity and outcome analysis.

Authors:  Pierpaolo Biondetti; Mark G Vangel; Rita M Lahoud; Felipe S Furtado; Bruce R Rosen; David Groshar; Lina G Canamaque; Lale Umutlu; Eric W Zhang; Umar Mahmood; Subba R Digumarthy; Jo-Anne O Shepard; Onofrio A Catalano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-07       Impact factor: 9.236

9.  Comparing the diagnostic value of 18F-FDG-PET/CT versus CT for differentiating benign and malignant solitary pulmonary nodules: a meta-analysis.

Authors:  Yuzhu Jia; Wanfeng Gong; Zhiping Zhang; Gaofeng Tu; Jiapeng Li; Fanfan Xiong; Hongtao Hou; Yunyi Zhang; Meiqian Wu; Liping Zhang
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

10.  Dynamic contrast-enhanced MRI versus 18F-FDG PET/CT: Which is better in differentiation between malignant and benign solitary pulmonary nodules?

Authors:  Feng Feng; Fulin Qiang; Aijun Shen; Donghui Shi; Aiyan Fu; Haiming Li; Mingzhu Zhang; Ganlin Xia; Peng Cao
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.